`

Lexeo Therapeutics

Biotechnology Research

Last Updated: November 20, 2025
Sign Up to View More
Revenue
$654.00K
funding-icon Total Funding
$280.00M
Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs
Recent News

Frequently Asked Questions About Lexeo Therapeutics

What does Lexeo therapeutics do?+

Based in New York City, Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, Lexeo partners with preeminent institutions on the cutting edge of gene therapy research. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4 associated Alzheimers disease programs, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug...

What is Lexeo therapeutics's industry? +

Lexeo therapeutics operates in the Biotechnology research industry.

What is Lexeo therapeutics's revenue? +

Lexeo therapeutics's revenue is $654.00k

What is Lexeo therapeutics's company size? +

Lexeo therapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free